Sarepta Therapeutics, Inc. - COM (SRPT)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
80 M
Holdings value Q1 2024
$10.3 B
Value change Q1 2024
+$194 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
393
Number of buys Q1 2024
205
Number of sells Q1 2024
-168
Average buys Q1 2024 %
+0.006%
Average sells Q1 2024 %
-0.003%
CUSIP
803607100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 80 M $10.3 B +$194 M $129.46 393
2023 Q4 79.3 M $7.65 B -$372 M $96.43 391
2023 Q3 79.1 M $9.59 B +$172 M $121.22 391
2023 Q2 80.1 M $9.17 B -$53.9 M $114.52 401
2023 Q1 76.5 M $10.5 B -$58.8 M $137.83 414
2022 Q4 78.1 M $10.1 B +$85.8 M $129.58 405
2022 Q3 77.4 M $8.55 B +$599 M $110.54 358
2022 Q2 71.4 M $5.35 B +$109 M $74.96 303
2022 Q1 72.1 M $5.63 B +$61.5 M $78.12 309
2021 Q4 70.7 M $6.37 B +$536 M $90.05 320
2021 Q3 64.8 M $5.99 B +$135 M $92.48 295
2021 Q2 63.9 M $4.97 B -$93.9 M $77.74 317
2021 Q1 65.4 M $4.87 B -$732 M $74.53 341
2020 Q4 70.1 M $11.9 B -$166 M $170.49 429
2020 Q3 71.6 M $10.1 B -$330 M $140.43 394
2020 Q2 73.4 M $11.8 B +$154 M $160.34 401
2020 Q1 72.6 M $7.1 B -$31.7 M $97.82 339
2019 Q4 72.8 M $9.4 B -$5.61 M $129.04 380
2019 Q3 72.6 M $5.47 B -$253 M $75.32 333
2019 Q2 71.1 M $10.8 B +$369 M $151.95 351
2019 Q1 70.4 M $8.4 B +$283 M $119.19 354
2018 Q4 68.1 M $7.43 B +$733 M $109.13 326
2018 Q3 60 M $9.7 B +$262 M $161.51 337
2018 Q2 59.8 M $7.9 B +$569 M $132.18 308
2018 Q1 56.4 M $4.17 B +$184 M $74.09 266
2017 Q4 55.2 M $3.07 B +$54.9 M $55.64 247
2017 Q3 53.6 M $2.44 B +$525 M $45.36 228
2017 Q2 42.6 M $1.44 B +$82.2 M $33.71 186
2017 Q1 40.7 M $1.2 B +$219 M $29.60 177
2016 Q4 39.2 M $1.07 B -$168 M $27.43 179
2016 Q3 42.3 M $2.59 B +$579 M $61.41 188
2016 Q2 34.2 M $653 M -$12.9 M $19.07 151
2016 Q1 34.8 M $679 M +$86.3 M $19.52 135
2015 Q4 28.5 M $1.1 B +$34.8 M $38.58 152
2015 Q3 27.8 M $891 M +$36.3 M $32.11 150
2015 Q2 26.2 M $797 M +$87.1 M $30.43 131
2015 Q1 24.2 M $321 M -$7.61 M $13.28 112
2014 Q4 24.5 M $354 M -$43.8 M $14.47 117
2014 Q3 26 M $548 M -$18.9 M $21.10 121
2014 Q2 26.6 M $794 M +$16.3 M $29.79 125
2014 Q1 26.6 M $638 M -$12.2 M $24.03 117